Latest Articles

Publication Date
Commentary on "Global, regional, and national burden of endometriosis among women of childbearing age from 1990 to 2021: a cross-sectional analysis from the 2021 global burden of disease study" [Letter].

Published: Dec. 16, 2025, midnight
ENDOMETRIOSIS IN WOMEN OF REPRODUCTIVE AGE IN KAZAKHSTAN: DIAGNOSTIC AND THERAPEUTIC DIFFICULTIES.

This review aims to examine the current diagnostic and therapeutic challenges associated with endometriosis in women of reproductive age in Kazakhstan and globally. The goal is to identify existing gaps …

Published: Dec. 12, 2025, midnight
Coexistence of gynecological pathology with endometriosis and adenomyosis.

Both endometriosis and adenomyosis can impact quality of life. Endometriosis is a chronic, benign, condition characterized by the growth of endometrium outside the uterus, which affects ~10% of women from …

Published: Dec. 12, 2025, midnight
Impact of estetrol and drospirenone combination therapy on alleviation of the pelvic pain of endometriosis: a randomized control trial.

To study the impact of estetrol (E4), a novel native estrogen with selective tissue activity, on endometriosis-associated pelvic pain (EAPP) and global impressions of endometriosis pain.

Published: Dec. 8, 2025, midnight
Impact of Physical Activity on Ovarian Response: A Prospective Study Among In Vitro Fertilization Patients.

Introduction Scientific evidence has shown that regular physical activity (PA) is beneficial to health. However, no consensus has been reached on the association between PA and the success rates of …

Published: Dec. 7, 2025, midnight
Bridging bench to bedside: Exosome‑based strategies for endometriosis diagnosis and treatment (Review).

Endometriosis is a complex, chronic inflammatory gynecological disorder with estrogen‑dependent characteristics that severely impairs the quality of life of women and potentially leads to infertility. However, its pathogenesis remains poorly …

Published: Dec. 5, 2025, midnight
Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development - The Manila Times

Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development The Manila Times

Published: Dec. 4, 2025, 12:30 p.m.
Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development - Laotian Times

Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development Laotian Times

Published: Dec. 4, 2025, 12:08 p.m.
Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development - PR Newswire

Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development PR Newswire

Published: Dec. 4, 2025, 12:08 p.m.
Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development - acrofan.com

Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development acrofan.com

Published: Dec. 4, 2025, 11:08 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!